Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis
Steve Kanters(University of British Columbia), Nick Bansback(University of British Columbia), Rebecca Zash(Beth Israel Deaconess Medical Center), Michael J. Zoratti(Impact), Martina Penazzato(World Health Organization), Nathan Ford(World Health Organization), Tamara Kredo(South African Medical Research Council), Ajay Rangaraj(Joint United Nations Programme on HIV/AIDS), Aslam H. Anis(Centre for Advancing Health Outcomes), Mohammad Ehsanul Karim(Providence Health Care), Alexandra Calmy(University Hospital of Geneva), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Kristian Thorlund(McMaster University), Meg Doherty(World Health Organization), Marco Vitória(World Health Organization)
Cited by 135
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
|Journal of Clinical Epidemiology|2012|761